Skip to main content
. Author manuscript; available in PMC: 2025 Aug 22.
Published in final edited form as: Clin Chem. 2017 Sep 13;63(11):1705–1713. doi: 10.1373/clinchem.2016.270751

Table 3.

Race-stratified Lp(a)-related risk of prevalent CAVD.a

Lp(a)-M (mg/dL) Lp(a)-C (mg/dL) Lp(a)-P (nmol/L)
Black
 Upper 15th% cutoff value 83.9 9.9 167
  Estimated RR 1.50 1.50 1.36
  95% CI (1.02–2.21) (1.02–2.21) (0.95–1.96)
  P value 0.04 0.04 0.10
White
 Upper 15th% cutoff value 49.3 5.7 102
  Estimated RR 1.71 1.74 1.74
  95% CI (1.37–2.14) (1.37–2.21) (1.37–2.20)
  P value <0.0001 <0.0001 <0.0001
Chinese-American
 Upper 15th% cutoff value 36.2 3.0 62
  Estimated RR 1.847 1.949 1.725
  95% CI (0.45–7.53) (0.72–5.29) (0.40–7.54)
  P value 0.39 0.19 0.47
Hispanic
 Upper 15th% cutoff value 46.0 4.6 93
  Estimated RR 1.26 1.50 1.50
  95% CI (0.84–1.88) (1.07–2.11) (1.06–2.12)
  P value 0.26 0.02 0.02

The P values are in bold to highlight the significance.

a

Relative risk ratios (RR) and 95% CI are presented for individuals in respective upper 15th percentiles for each Lp(a) marker. Adjustments were made for age, sex, hypertension, smoking, education status, diabetes, LDL-C, and HDL-C. Upper 15th percentile cutoff values are shown for each analyte and racial/ethnic group.